Ipamorelin is a selective growth hormone secretagogue commonly studied in laboratory models involving growth hormone release, IGF-1 signaling, and endocrine system regulation. This research peptide is frequently used in experimental settings focused on pulsatile hormone release and
targeted GH pathway activation.
Ipamorelin is a synthetic pentapeptide designed for high receptor selectivity, allowing it to stimulate growth hormone release with minimal interaction across other hormonal pathways. Its focused signaling profile makes it a widely studied compound in controlled endocrine research models.
Mechanism of Action
Ipamorelin is studied for its interaction with the ghrelin receptor (GHS-R1a), supporting regulated growth hormone release.
Research has explored associations with:
• Stimulation of growth hormone (GH) release from the anterior pituitary
• Support for pulsatile, physiologic hormone signaling patterns
• Modulation of somatostatin-related inhibitory pathways
• Increased IGF-1 signaling activity
• Minimal interaction with cortisol, prolactin, and ACTH pathways
Research Applications
Ipamorelin is commonly studied in laboratory settings involving:
• Growth hormone and IGF-1 pathway research
• Endocrine system signaling and regulation studies
• Muscle and tissue recovery models
• Metabolic and age-related signaling research
Product Specifications
• Peptide Content: 5mg Lyophilized Peptide
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Purity: ≥98% verified by HPLC testing
• Form: Lyophilized peptide powder
• Storage: Store lyophilized peptide frozen. After reconstitution, maintain refrigerated conditions (2–8°C) and avoid repeated freeze-thaw cycles.
Research Use Notice
This product is intended strictly for laboratory research and analytical purposes only.
• Not for human consumption
• Not for veterinary use
• Not intended for ingestion, injection, or bodily administration
• Not a drug, food, cosmetic, or dietary supplement
All information provided is for educational and scientific reference purposes only.